| UniProt ID | CDC6_HUMAN | |
|---|---|---|
| UniProt AC | Q99741 | |
| Protein Name | Cell division control protein 6 homolog | |
| Gene Name | CDC6 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 560 | |
| Subcellular Localization | Nucleus . Cytoplasm . The protein is nuclear in G1 and cytoplasmic in S-phase cells (PubMed:9566895). | |
| Protein Description | Involved in the initiation of DNA replication. Also participates in checkpoint controls that ensure DNA replication is completed before mitosis is initiated.. | |
| Protein Sequence | MPQTRSQAQATISFPKRKLSRALNKAKNSSDAKLEPTNVQTVTCSPRVKALPLSPRKRLGDDNLCNTPHLPPCSPPKQGKKENGPPHSHTLKGRRLVFDNQLTIKSPSKRELAKVHQNKILSSVRKSQEITTNSEQRCPLKKESACVRLFKQEGTCYQQAKLVLNTAVPDRLPAREREMDVIRNFLREHICGKKAGSLYLSGAPGTGKTACLSRILQDLKKELKGFKTIMLNCMSLRTAQAVFPAIAQEICQEEVSRPAGKDMMRKLEKHMTAEKGPMIVLVLDEMDQLDSKGQDVLYTLFEWPWLSNSHLVLIGIANTLDLTDRILPRLQAREKCKPQLLNFPPYTRNQIVTILQDRLNQVSRDQVLDNAAVQFCARKVSAVSGDVRKALDVCRRAIEIVESDVKSQTILKPLSECKSPSEPLIPKRVGLIHISQVISEVDGNRMTLSQEGAQDSFPLQQKILVCSLMLLIRQLKIKEVTLGKLYEAYSKVCRKQQVAAVDQSECLSLSGLLEARGILGLKRNKETRLTKVFFKIEEKEIEHALKDKALIGNILATGLP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 20 | Phosphorylation | SFPKRKLSRALNKAK HCCHHHHHHHHHHHC | 20.67 | 21406692 | |
| 25 | Ubiquitination | KLSRALNKAKNSSDA HHHHHHHHHCCCCCC | 62.68 | 21906983 | |
| 27 | Ubiquitination | SRALNKAKNSSDAKL HHHHHHHCCCCCCCC | 60.00 | 21906983 | |
| 33 | Ubiquitination | AKNSSDAKLEPTNVQ HCCCCCCCCCCCCCE | 59.37 | - | |
| 37 | Phosphorylation | SDAKLEPTNVQTVTC CCCCCCCCCCEEEEC | 38.35 | 23927012 | |
| 41 | Phosphorylation | LEPTNVQTVTCSPRV CCCCCCEEEECCCCC | 17.31 | 29255136 | |
| 43 | Phosphorylation | PTNVQTVTCSPRVKA CCCCEEEECCCCCEE | 15.62 | 23401153 | |
| 45 | Phosphorylation | NVQTVTCSPRVKALP CCEEEECCCCCEECC | 13.33 | 29255136 | |
| 49 | Ubiquitination | VTCSPRVKALPLSPR EECCCCCEECCCCCC | 45.55 | - | |
| 54 | Phosphorylation | RVKALPLSPRKRLGD CCEECCCCCCCCCCC | 22.25 | 9889196 | |
| 67 | Phosphorylation | GDDNLCNTPHLPPCS CCCCCCCCCCCCCCC | 15.87 | 25159151 | |
| 74 | Phosphorylation | TPHLPPCSPPKQGKK CCCCCCCCCCCCCCC | 50.43 | 9889196 | |
| 88 | Phosphorylation | KENGPPHSHTLKGRR CCCCCCCCCCCCCCE | 24.76 | 25159151 | |
| 90 | Phosphorylation | NGPPHSHTLKGRRLV CCCCCCCCCCCCEEE | 32.93 | 20860994 | |
| 92 | Acetylation | PPHSHTLKGRRLVFD CCCCCCCCCCEEEEC | 52.07 | 19343071 | |
| 92 | Ubiquitination | PPHSHTLKGRRLVFD CCCCCCCCCCEEEEC | 52.07 | - | |
| 103 | Phosphorylation | LVFDNQLTIKSPSKR EEECCCEEECCCCHH | 19.32 | 24732914 | |
| 105 | Acetylation | FDNQLTIKSPSKREL ECCCEEECCCCHHHH | 51.59 | 19343071 | |
| 106 | Phosphorylation | DNQLTIKSPSKRELA CCCEEECCCCHHHHH | 30.47 | 9889196 | |
| 108 | Phosphorylation | QLTIKSPSKRELAKV CEEECCCCHHHHHHH | 51.97 | 24732914 | |
| 109 | Acetylation | LTIKSPSKRELAKVH EEECCCCHHHHHHHH | 53.96 | 19343071 | |
| 114 | Ubiquitination | PSKRELAKVHQNKIL CCHHHHHHHHHHHHH | 53.53 | - | |
| 119 | Ubiquitination | LAKVHQNKILSSVRK HHHHHHHHHHHHHHH | 38.15 | - | |
| 122 | Phosphorylation | VHQNKILSSVRKSQE HHHHHHHHHHHHHHC | 30.20 | 24732914 | |
| 123 | Phosphorylation | HQNKILSSVRKSQEI HHHHHHHHHHHHHCC | 23.61 | 24732914 | |
| 126 | Ubiquitination | KILSSVRKSQEITTN HHHHHHHHHHCCCCC | 55.10 | - | |
| 127 | Phosphorylation | ILSSVRKSQEITTNS HHHHHHHHHCCCCCC | 23.60 | 25159151 | |
| 131 | Phosphorylation | VRKSQEITTNSEQRC HHHHHCCCCCCCCCC | 21.12 | 24732914 | |
| 132 | Phosphorylation | RKSQEITTNSEQRCP HHHHCCCCCCCCCCC | 42.27 | 24732914 | |
| 134 | Phosphorylation | SQEITTNSEQRCPLK HHCCCCCCCCCCCCC | 32.77 | 21815630 | |
| 151 | Acetylation | SACVRLFKQEGTCYQ HHHHHHHHCCCCHHH | 52.62 | 26051181 | |
| 151 | Sumoylation | SACVRLFKQEGTCYQ HHHHHHHHCCCCHHH | 52.62 | - | |
| 151 | Sumoylation | SACVRLFKQEGTCYQ HHHHHHHHCCCCHHH | 52.62 | - | |
| 151 | Ubiquitination | SACVRLFKQEGTCYQ HHHHHHHHCCCCHHH | 52.62 | - | |
| 166 | Phosphorylation | QAKLVLNTAVPDRLP HHHHHHCCCCCCCCC | 25.52 | 29632367 | |
| 194 | Ubiquitination | REHICGKKAGSLYLS HHHHCCCCCCCEEEC | 43.17 | - | |
| 199 | Phosphorylation | GKKAGSLYLSGAPGT CCCCCCEEECCCCCC | 10.66 | 29496907 | |
| 208 | Ubiquitination | SGAPGTGKTACLSRI CCCCCCCHHHHHHHH | 32.55 | - | |
| 220 | Ubiquitination | SRILQDLKKELKGFK HHHHHHHHHHHCCCC | 53.11 | - | |
| 221 | Ubiquitination | RILQDLKKELKGFKT HHHHHHHHHHCCCCH | 75.48 | - | |
| 235 | Phosphorylation | TIMLNCMSLRTAQAV HHHHHHCCHHHHHHH | 19.52 | 29083192 | |
| 261 | Ubiquitination | EVSRPAGKDMMRKLE HCCCHHHHHHHHHHH | 44.55 | - | |
| 379 | Ubiquitination | AVQFCARKVSAVSGD HHHHHHHHHHHCCCH | 23.24 | - | |
| 381 | Phosphorylation | QFCARKVSAVSGDVR HHHHHHHHHCCCHHH | 26.45 | 20068231 | |
| 384 | Phosphorylation | ARKVSAVSGDVRKAL HHHHHHCCCHHHHHH | 29.06 | 20068231 | |
| 389 | Ubiquitination | AVSGDVRKALDVCRR HCCCHHHHHHHHHHH | 53.82 | - | |
| 406 | Ubiquitination | EIVESDVKSQTILKP HHHHCCCCCCCCCCC | 41.66 | - | |
| 407 | Phosphorylation | IVESDVKSQTILKPL HHHCCCCCCCCCCCH | 32.19 | 24732914 | |
| 409 | Phosphorylation | ESDVKSQTILKPLSE HCCCCCCCCCCCHHH | 35.05 | 29214152 | |
| 412 | Ubiquitination | VKSQTILKPLSECKS CCCCCCCCCHHHCCC | 39.81 | - | |
| 415 | Phosphorylation | QTILKPLSECKSPSE CCCCCCHHHCCCCCC | 49.85 | 24732914 | |
| 418 | Ubiquitination | LKPLSECKSPSEPLI CCCHHHCCCCCCCCC | 62.44 | - | |
| 419 | Phosphorylation | KPLSECKSPSEPLIP CCHHHCCCCCCCCCC | 45.37 | 25159151 | |
| 421 | Phosphorylation | LSECKSPSEPLIPKR HHHCCCCCCCCCCCC | 59.96 | 21815630 | |
| 427 | Ubiquitination | PSEPLIPKRVGLIHI CCCCCCCCCEEEEEH | 53.36 | - | |
| 478 | Ubiquitination | LIRQLKIKEVTLGKL HHHHHCCCCCHHHHH | 44.54 | - | |
| 481 | Phosphorylation | QLKIKEVTLGKLYEA HHCCCCCHHHHHHHH | 30.77 | - | |
| 484 | Ubiquitination | IKEVTLGKLYEAYSK CCCCHHHHHHHHHHH | 51.51 | - | |
| 491 | Ubiquitination | KLYEAYSKVCRKQQV HHHHHHHHHHHHHHC | 32.45 | - | |
| 495 | Ubiquitination | AYSKVCRKQQVAAVD HHHHHHHHHHCEEEC | 39.70 | - | |
| 527 | Phosphorylation | GLKRNKETRLTKVFF CCCCCCCCCCEEEEE | 32.37 | 22210691 | |
| 531 | Ubiquitination | NKETRLTKVFFKIEE CCCCCCEEEEEEECH | 41.45 | - | |
| 535 | Ubiquitination | RLTKVFFKIEEKEIE CCEEEEEEECHHHHH | 37.43 | - | |
| 539 | Ubiquitination | VFFKIEEKEIEHALK EEEEECHHHHHHHHH | 51.72 | - | |
| 546 | Ubiquitination | KEIEHALKDKALIGN HHHHHHHHCHHHHHH | 58.95 | - | |
| 548 | Ubiquitination | IEHALKDKALIGNIL HHHHHHCHHHHHHHH | 43.43 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 37 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 54 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| 74 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| 106 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | FZR1 | Q9UM11 | PMID:10995389 |
| - | K | Ubiquitination | E3 ubiquitin ligase | CCNF | P41002 | PMID:26818844 |
| - | K | Ubiquitination | E3 ubiquitin ligase | HUWE1 | Q7Z6Z7 | PMID:18617514 |
| - | K | Ubiquitination | E3 ubiquitin ligase | TOM1 | O60784 | PMID:23129771 |
| - | K | Ubiquitination | E3 ubiquitin ligase | DTL | Q9NZJ0 | PMID:24434580 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CDC6_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDC6_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 613805 | Meier-Gorlin syndrome 5 (MGORS5) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45 AND SER-54, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-166, AND MASSSPECTROMETRY. | |